These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 3554163)

  • 1. [Immunogenicity of MC Lente Novo insulin].
    Rogala H; Lawecki J; Czyzyk A
    Pol Arch Med Wewn; 1986 Sep; 76(3):172-6. PubMed ID: 3554163
    [No Abstract]   [Full Text] [Related]  

  • 2. Human insulin.
    Roberts RJ
    Iowa Med; 1984 Mar; 74(3):116-8. PubMed ID: 6373658
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin antibodies and clinical complications in diabetics treated for five years with lente or sulfated insulin.
    Little JA; Lee R; Sebriakova M; Csima A
    Diabetes; 1977 Oct; 26(10):980-8. PubMed ID: 561729
    [No Abstract]   [Full Text] [Related]  

  • 4. [The antigenicity of various new chromatographically purified depot insulin preparations].
    Graber D; Fankhauser S
    Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 6. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
    Bruni B; Gamba S; Regis G; Turco GL
    Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of semisynthetic human insulin.
    Rogala H; Lawecki J; Czyzyk A
    Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Diabetologia; 1974 Jun; 10(3):233-6. PubMed ID: 4845724
    [No Abstract]   [Full Text] [Related]  

  • 9. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
    Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
    Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic qualities of a lente preparation of swine insulins manufactured by Pharmachem].
    Andreev D; Bozadzhieva E; Pampulov L; Penchev I; Uzunova B
    Vutr Boles; 1977; 16(6):59-66. PubMed ID: 341532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin.
    Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA
    Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial with monocomponent lente insulins. Preliminary report.
    Bruni B; D'Alberto M; Osenda M; Ricci C; Turco GL
    Diabetologia; 1973 Dec; 9(6):492-8. PubMed ID: 4589824
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of insulin lipoatrophy with monocomponent insulin.
    Teuscher A
    Diabetologia; 1974 Jun; 10(3):211-4. PubMed ID: 4845721
    [No Abstract]   [Full Text] [Related]  

  • 15. [The study of insulin antibodies in different forms of diabetes mellitus].
    Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin.
    Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H
    Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical evaluation of the mono-peak porcine and bovine insulin preparations, Maxirapid and Lente].
    Sroczyński J; Pietraszek F; Bresler M; Kuleszyńska G
    Pol Tyg Lek; 1986 Mar; 41(11):339-42. PubMed ID: 3520515
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity of human insulin (Novo) or pork monocomponent insulin in HLA-DR-typed insulin-dependent diabetic individuals.
    Schernthaner G; Borkenstein M; Fink M; Mayr WR; Menzel J; Schober E
    Diabetes Care; 1983; 6 Suppl 1():43-8. PubMed ID: 6343038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
    Göbel P; Kramer W; Heni F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.